Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Please Clarify for me ! Does this include non optimized ?
View:
Post by Oden6570 on Mar 30, 2024 8:25am

Please Clarify for me ! Does this include non optimized ?

If this does include the original non optimized treated patients , What would the TR and CR rates be ? Regardless stellar results IMHO, The worst of the worst  NMIBC patients facing Bladder Removal or potential death and now Cancer free after 1 TLT Treatment , Only In Canada you say ! On the Vulture exchange were all companies and retail investors are raped and pilleged by scalliwags with impunity , how do we fight back ?

I mean holy cow Batman why the Bleep is this company's share price so low ? # POW , # BAM , # WHOP , No Idea Robin  back to the Bat Cave now gather all the loose change we can ! At some point soon the tide will change ! I have decided to reduce Alfords pay and buy more shares at this price point !

Dr. Arkady Mandel, MD, PhD, DSc, Chief Scientific Officer of Theralase® stated, "The interim clinical data of Study II to date has proven to be world-class. Study II has demonstrated an ability to destroy urothelial cell carcinoma in a patient's bladder for a total response of 69% and a duration of that total response of 43%, for patients treated with the optimized Study Procedure. The primary benefits of the Theralase® technology versus competitive technologies are the high efficacy rates (patients achieve a CR in approximately 60% of the cases after only one Study Procedure), high duration of response and high safety margin (no SAEs directly associated with the Study Drug or Study Device); therefore, the Theralase® technology presents a safe, effective alternative therapy for patients, who are at risk of having their bladder removed."


THERALASE TECHNOLOGIES INC. (:TLT) Theralase(R) Release's 4Q2023 Interim Financial Statements (webdisclosure.com)
Comment by DeathXray33 on Mar 30, 2024 12:49pm
"Regardless stellar results IMHO, The worst of the worst NMIBC patients facing Bladder Removal or potential death and now Cancer free after 1 TLT Treatment , Only In Canada you say ! On the Vulture exchange were all companies and retail investors are raped and pilleged by scalliwags with impunity , how do we fight back ? I mean holy cow Batman why the Bleep is this company's share price ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250